Ye Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ye Li has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Si Jin
Department of Endocrinology, Institute of Geriatric Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publications Xiong Jia
Department of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan , Hubei , China , 430077
5 shared publicationsLin Zhu
Department of endocrinology, Institute of geriatric medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan , Hubei , China , 430077
4 shared publicationsGuangjie Wu
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology . Wuhan , Hubei , China , 430030
3 shared publicationsLing Wang
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology . Wuhan , Hubei , China , 430030
3 shared publicationsWenjing Li
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology . Wuhan , Hubei , China , 430030
3 shared publications
Latest Publications
- Open Access
- 25 July 2025
- Published by Elsevier in Tuberculosis
- Vol. 154, 102676
Biomarkers for diagnosing pulmonary tuberculosis in adolescents: Peripheral blood monocyte myotubularin-related protein 4 and oncostatin M genes
- 25 July 2025
- Published by Elsevier in Tuberculosis
- Vol. 154, 102676
Open AccessBiomarkers for diagnosing pulmonary tuberculosis in adolescents: Peripheral blood monocyte myotubularin-related protein 4 and oncostatin M genes
- 26 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 504
3D Trajectory Visualization for Robotic-Assisted Surgery Review
Reviewing endoscopic video recordings of surgical cases is an increasingly common portion of minimally-invasive surgical training. However, the 2-dimensional (2D) camera-centric representations of video frames obscure the 3D reality of surgical workspaces. Moreover, studies have shown that surgical workspace and instrument motion metrics during surgery, like speed and smoothness, correlate to skill and specific clinical outcomes. Reviewing and comparing visualizations of 3D instrument trajectories and workspaces could aid minimally-invasive surgical training, learning, and assessment. Robotic-assisted surgery (RAS) performed with the da Vinci® System provides a unique opportunity to unobtrusively record 3D movements during surgery and generate visualizations for post-surgical review. 3D trajectory plots can be generated for the tool instrument in the patient-side cart or for the hand controller in the surgeon-side console of the da Vinci® Surgical System. They provide unique information that cannot be presented in surgical video and may help surgeons interpret instrument motion metrics, like average speed or smoothness. To allow surgeons to review their procedure cases in a structured way, 3D visualizations were made for individual surgical steps, in which the procedure achieves a clinically meaningful goal during the surgery. Extracted segments of kinematics data corresponding to the surgical steps for tool instruments were aligned with tool labels, registered to the same global coordinate system and centered to the workspace. In this way, the 3D trajectory plots of instruments in the patient-side can be compared across different surgical steps. With these representations, 3D trajectories can be used to derive insights about intra-operative behavior and inform surgeon training for the following reasons: (1) 3D trajectory plots provide information that was not captured by endoscopes (e.g., hand controller movements); (2) 3D visualization of instruments or hand controllers help surgeons to interpret objective performance metrics (e.g., speed and smoothness) that were presented numerically; (3) 3D trajectory plots provide unique information that neither endoscope video nor objective performance metrics can present (e.g., workspace shape). Visualizations of the 3D trajectories of instruments during minimally-invasive surgery may change how surgeons review and learn from their own cases and those of others.
- 26 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 504
3D Trajectory Visualization for Robotic-Assisted Surgery Review
Reviewing endoscopic video recordings of surgical cases is an increasingly common portion of minimally-invasive surgical training. However, the 2-dimensional (2D) camera-centric representations of video frames obscure the 3D reality of surgical workspaces. Moreover, studies have shown that surgical workspace and instrument motion metrics during surgery, like speed and smoothness, correlate to skill and specific clinical outcomes. Reviewing and comparing visualizations of 3D instrument trajectories and workspaces could aid minimally-invasive surgical training, learning, and assessment. Robotic-assisted surgery (RAS) performed with the da Vinci® System provides a unique opportunity to unobtrusively record 3D movements during surgery and generate visualizations for post-surgical review. 3D trajectory plots can be generated for the tool instrument in the patient-side cart or for the hand controller in the surgeon-side console of the da Vinci® Surgical System. They provide unique information that cannot be presented in surgical video and may help surgeons interpret instrument motion metrics, like average speed or smoothness. To allow surgeons to review their procedure cases in a structured way, 3D visualizations were made for individual surgical steps, in which the procedure achieves a clinically meaningful goal during the surgery. Extracted segments of kinematics data corresponding to the surgical steps for tool instruments were aligned with tool labels, registered to the same global coordinate system and centered to the workspace. In this way, the 3D trajectory plots of instruments in the patient-side can be compared across different surgical steps. With these representations, 3D trajectories can be used to derive insights about intra-operative behavior and inform surgeon training for the following reasons: (1) 3D trajectory plots provide information that was not captured by endoscopes (e.g., hand controller movements); (2) 3D visualization of instruments or hand controllers help surgeons to interpret objective performance metrics (e.g., speed and smoothness) that were presented numerically; (3) 3D trajectory plots provide unique information that neither endoscope video nor objective performance metrics can present (e.g., workspace shape). Visualizations of the 3D trajectories of instruments during minimally-invasive surgery may change how surgeons review and learn from their own cases and those of others.
- Open Access
- 18 July 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (11) , e23476
The mRNA expression of visfatin and lipocalin‐2 in peripheral blood mononuclear cells from patients with pulmonary tuberculosis
Background: In this study, we aimed to assess mRNA expressions of visfatin and lipocalin‐2 in peripheral blood mononuclear cells (PBMCs) from patients with pulmonary tuberculosis (PTB).Methods: Overall, 79 PTB patients and 71 healthy controls were enrolled. In PBMCs, mRNA expressions of visfatin and lipocalin‐2 were detected using real‐time quantitative polymerase chain reaction (qRT‐PCR), and the diagnostic value of these adipokine mRNAs in PTB patients was calculated through receiver operating characteristic (ROC) analysis.Results: In PBMCs from PTB patients, the visfatin mRNA level was significantly higher than in healthy controls (P < .001), with no significant association between the lipocalin‐2 mRNA level and PTB patients (P = .933). In PTB patients, lipocalin‐2 mRNA expression positively correlated with the erythrocyte sedimentation rate (ESR) (P = .010). However, the visfatin mRNA level was not associated with any major clinical and laboratory parameter in PTB patients. The ROC curve demonstrated that visfatin could help distinguish PTB patients from healthy controls, with an optimal cutoff value of 0.645 and a corresponding sensitivity of 79.7%.Conclusions: The altered visfatin mRNA expression indicated that this adipokine might play a role in PTB and could be an auxiliary biomarker for PTB diagnosis.
- 18 July 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (11) , e23476
Open AccessThe mRNA expression of visfatin and lipocalin‐2 in peripheral blood mononuclear cells from patients with pulmonary tuberculosis
Background: In this study, we aimed to assess mRNA expressions of visfatin and lipocalin‐2 in peripheral blood mononuclear cells (PBMCs) from patients with pulmonary tuberculosis (PTB).Methods: Overall, 79 PTB patients and 71 healthy controls were enrolled. In PBMCs, mRNA expressions of visfatin and lipocalin‐2 were detected using real‐time quantitative polymerase chain reaction (qRT‐PCR), and the diagnostic value of these adipokine mRNAs in PTB patients was calculated through receiver operating characteristic (ROC) analysis.Results: In PBMCs from PTB patients, the visfatin mRNA level was significantly higher than in healthy controls (P < .001), with no significant association between the lipocalin‐2 mRNA level and PTB patients (P = .933). In PTB patients, lipocalin‐2 mRNA expression positively correlated with the erythrocyte sedimentation rate (ESR) (P = .010). However, the visfatin mRNA level was not associated with any major clinical and laboratory parameter in PTB patients. The ROC curve demonstrated that visfatin could help distinguish PTB patients from healthy controls, with an optimal cutoff value of 0.645 and a corresponding sensitivity of 79.7%.Conclusions: The altered visfatin mRNA expression indicated that this adipokine might play a role in PTB and could be an auxiliary biomarker for PTB diagnosis.
- 1 May 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 318 (5) , C857-C869
Hydrogen sulfide rescues high glucose-induced migration dysfunction in HUVECs by upregulating miR-126-3p
Diabetes (especially Type II) is one of the primary threats to cardiovascular health. Wound healing defects and vascular dysfunction are common in diabetic patients, and the primary cause of deterioration is sustained high plasma glucose. microRNA, a noncoding RNA, has regulatory functions that are critical to maintaining homeostasis. MicroRNA (miR)-126-3p is a potential diabetes biomarker and a proangiogenic factor, and its plasma level decreases in diabetic patients. Previous studies have revealed the proangiogenic character of the gasotransmitter hydrogen sulfide (H2S). However, little is known about the relationship between H2S and miR-126-3p when the extracellular glucose level is high, let alone their influences on deteriorated endothelial cell migration, a key component of angiogenesis, which is crucial for wound healing. Human umbilical vein endothelial cells (HUVECs) were treated with high glucose (33.3 mmol/L) or normal glucose (5.5 mmol/L) for 48 h. Affymetrix miRNA profiling and real-time PCR were used to validate the miRNA expression. An H2S probe (HSip-1) was used to detect endogenous H2S. Scratch wound-healing assays were used to evaluate HUVEC migration. The protein levels were quantified by Western blot. Both exogenous and endogenous H2S could upregulate the miR-126-3p levels in HUVECs or muscle tissue. High glucose decreased the H2S level and the protein expression of the H2S-producing enzyme cystathionine γ-lyase (CSE) in HUVECs; however, the DNA methyltransferase 1 (DNMT1) protein level was upregulated. CSE overexpression not only increased the miR-126-3p level by decreasing the DNMT1 protein level but also rescued the deteriorated cell migration in HUVECs treated with high glucose. DNMT1 overexpression decreased the miR-126-3p level and inhibited the migration of HUVECs, whereas silencing DNMT1 improved cell migration. High glucose decreased the endogenous H2S and miR-126-3p levels and increased the DNMT1 expression, thus inducing the migration dysfunction of HUVECs. Treatment with exogenous H2S or the overexpression of the endogenously produced enzyme CSE would rescue this migration dysfunction through H2S-DNMT1-miR-126-3p.
- 1 May 2020
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 318 (5) , C857-C869
Hydrogen sulfide rescues high glucose-induced migration dysfunction in HUVECs by upregulating miR-126-3p
Diabetes (especially Type II) is one of the primary threats to cardiovascular health. Wound healing defects and vascular dysfunction are common in diabetic patients, and the primary cause of deterioration is sustained high plasma glucose. microRNA, a noncoding RNA, has regulatory functions that are critical to maintaining homeostasis. MicroRNA (miR)-126-3p is a potential diabetes biomarker and a proangiogenic factor, and its plasma level decreases in diabetic patients. Previous studies have revealed the proangiogenic character of the gasotransmitter hydrogen sulfide (H2S). However, little is known about the relationship between H2S and miR-126-3p when the extracellular glucose level is high, let alone their influences on deteriorated endothelial cell migration, a key component of angiogenesis, which is crucial for wound healing. Human umbilical vein endothelial cells (HUVECs) were treated with high glucose (33.3 mmol/L) or normal glucose (5.5 mmol/L) for 48 h. Affymetrix miRNA profiling and real-time PCR were used to validate the miRNA expression. An H2S probe (HSip-1) was used to detect endogenous H2S. Scratch wound-healing assays were used to evaluate HUVEC migration. The protein levels were quantified by Western blot. Both exogenous and endogenous H2S could upregulate the miR-126-3p levels in HUVECs or muscle tissue. High glucose decreased the H2S level and the protein expression of the H2S-producing enzyme cystathionine γ-lyase (CSE) in HUVECs; however, the DNA methyltransferase 1 (DNMT1) protein level was upregulated. CSE overexpression not only increased the miR-126-3p level by decreasing the DNMT1 protein level but also rescued the deteriorated cell migration in HUVECs treated with high glucose. DNMT1 overexpression decreased the miR-126-3p level and inhibited the migration of HUVECs, whereas silencing DNMT1 improved cell migration. High glucose decreased the endogenous H2S and miR-126-3p levels and increased the DNMT1 expression, thus inducing the migration dysfunction of HUVECs. Treatment with exogenous H2S or the overexpression of the endogenously produced enzyme CSE would rescue this migration dysfunction through H2S-DNMT1-miR-126-3p.
- 4 September 2019
- Published by Taylor & Francis in Autophagy
- Vol. 16 (6) , 1111-1129
CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis
Diabetes is a recognized high-risk factor for the development of atherosclerosis, in which macroautophagy/autophagy is emerging to play essential roles. The retention of low-density lipoprotein (LDL) particles in subendothelial space following transcytosis across the endothelium is the initial step of atherosclerosis. Here, we identified that high glucose could promote atherosclerosis by stimulating transcytosis of LDL. By inhibiting AMPK-MTOR-PIK3C3 pathway, high glucose suppresses the CAV-CAVIN-LC3B-mediated autophagic degradation of CAV1; therefore, more CAV1 is accumulated in the cytosol and utilized to form more caveolae in the cell membrane and facilitates the LDL transcytosis across endothelial cells. For a proof of concept, higher levels of lipids were accumulated in the subendothelial space of umbilical venous walls from pregnant women with gestational diabetes mellitus (GDM), compared to those of pregnant women without GDM. Our results reveal that high glucose stimulates LDL transcytosis by a novel CAV1-CAVIN1-LC3B signaling-mediated autophagic degradation pathway.
- 4 September 2019
- Published by Taylor & Francis in Autophagy
- Vol. 16 (6) , 1111-1129
CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis
Diabetes is a recognized high-risk factor for the development of atherosclerosis, in which macroautophagy/autophagy is emerging to play essential roles. The retention of low-density lipoprotein (LDL) particles in subendothelial space following transcytosis across the endothelium is the initial step of atherosclerosis. Here, we identified that high glucose could promote atherosclerosis by stimulating transcytosis of LDL. By inhibiting AMPK-MTOR-PIK3C3 pathway, high glucose suppresses the CAV-CAVIN-LC3B-mediated autophagic degradation of CAV1; therefore, more CAV1 is accumulated in the cytosol and utilized to form more caveolae in the cell membrane and facilitates the LDL transcytosis across endothelial cells. For a proof of concept, higher levels of lipids were accumulated in the subendothelial space of umbilical venous walls from pregnant women with gestational diabetes mellitus (GDM), compared to those of pregnant women without GDM. Our results reveal that high glucose stimulates LDL transcytosis by a novel CAV1-CAVIN1-LC3B signaling-mediated autophagic degradation pathway.
- Open Access
- 28 February 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3020
Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells
Elevated plasma low density lipoprotein (LDL) is an established risk factor for cardiovascular disease. In addition to being able to cross the endothelial barrier to become accumulated in subendothelial space and thereby initiate atherosclerosis, LDL may exert a direct effect on vascular endothelial cells through activation of LDL receptor and its downstream signaling. Whether LDL can modulate the signaling for autophagy in endothelial cells is not clear. The present study firstly demonstrated that LDL can suppress endothelial autophagy through activation of the PI3K/Akt/mTOR signaling pathway and can promote glucose uptake by translocating glucose transporter 1 (GLUT1) from cytoplasm to cell membrane, actions similar to those of insulin. A co-immunoprecipitation assay found that LDL receptor (LDLR) and insulin receptor (IR) formed a complex in HUVECs. Knock down of the insulin receptor by small interfering RNA blocked the suppression of autophagy by LDL, as well as the signaling pathway involved. We conclude that LDL may mimic the action of insulin in endothelial cells, which might partly explain the increased incidence of diabetes in patients receiving some LDL-lowering therapy.
- 28 February 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3020
Open AccessLow density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells
Elevated plasma low density lipoprotein (LDL) is an established risk factor for cardiovascular disease. In addition to being able to cross the endothelial barrier to become accumulated in subendothelial space and thereby initiate atherosclerosis, LDL may exert a direct effect on vascular endothelial cells through activation of LDL receptor and its downstream signaling. Whether LDL can modulate the signaling for autophagy in endothelial cells is not clear. The present study firstly demonstrated that LDL can suppress endothelial autophagy through activation of the PI3K/Akt/mTOR signaling pathway and can promote glucose uptake by translocating glucose transporter 1 (GLUT1) from cytoplasm to cell membrane, actions similar to those of insulin. A co-immunoprecipitation assay found that LDL receptor (LDLR) and insulin receptor (IR) formed a complex in HUVECs. Knock down of the insulin receptor by small interfering RNA blocked the suppression of autophagy by LDL, as well as the signaling pathway involved. We conclude that LDL may mimic the action of insulin in endothelial cells, which might partly explain the increased incidence of diabetes in patients receiving some LDL-lowering therapy.
- Open Access
- 19 October 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (61) , 103985-103995
Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop
Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-B/Sp1 loop Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop
- 19 October 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (61) , 103985-103995
Open AccessCavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop
Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-B/Sp1 loop Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop
- Open Access
- 12 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes
Critical Limb Ischemia (CLI) is common but uncommonly diagnosed. Improved recognition and early diagnostic markers for CLI are needed. Therefore, the aim of our study was to identify plasma biomarkers of CLI in patients with type 2 diabetes mellitus (T2DM). In this study, antibody-coated glass slide arrays were used to determine the plasma levels of 274 human cytokines in four matched cases of diabetes with and without CLI. Potential biomarkers were confirmed in an independent cohort by ELISA. After adjusting for confounding risk factors, only plasma level of Siglec-5 remained significantly associated with an increased odds ratio (OR) for diabetes with CLI by binary logistic regression analysis. Receiver operating characteristic (ROC) curve analysis revealed the optimal cut-off points for Siglec-5 was 153.1 ng/ml. After entering Siglec-5, the AUC was 0.99, which was higher than that of confounding risk factors only (AUC = 0.97, P < 0.05). Siglec-5 was expressed in plaques, but not in healthy artery wall in T2DM patients. Elevated plasma Siglec-5 was independently associated with CLI in T2DM. Plasma Siglec-5 levels are implicated as an early diagnostic marker of CLI in T2DM patients and it may become a target for the prevention or treatment of CLI in diabetes.
- 12 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Open AccessSiglec-5 is a novel marker of critical limb ischemia in patients with diabetes
Critical Limb Ischemia (CLI) is common but uncommonly diagnosed. Improved recognition and early diagnostic markers for CLI are needed. Therefore, the aim of our study was to identify plasma biomarkers of CLI in patients with type 2 diabetes mellitus (T2DM). In this study, antibody-coated glass slide arrays were used to determine the plasma levels of 274 human cytokines in four matched cases of diabetes with and without CLI. Potential biomarkers were confirmed in an independent cohort by ELISA. After adjusting for confounding risk factors, only plasma level of Siglec-5 remained significantly associated with an increased odds ratio (OR) for diabetes with CLI by binary logistic regression analysis. Receiver operating characteristic (ROC) curve analysis revealed the optimal cut-off points for Siglec-5 was 153.1 ng/ml. After entering Siglec-5, the AUC was 0.99, which was higher than that of confounding risk factors only (AUC = 0.97, P < 0.05). Siglec-5 was expressed in plaques, but not in healthy artery wall in T2DM patients. Elevated plasma Siglec-5 was independently associated with CLI in T2DM. Plasma Siglec-5 levels are implicated as an early diagnostic marker of CLI in T2DM patients and it may become a target for the prevention or treatment of CLI in diabetes.
- 1 June 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 90, 244-252
Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions
- 1 June 2017
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 90, 244-252
Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions
- Open Access
- 17 March 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 44659
TNF-α stimulates endothelial palmitic acid transcytosis and promotes insulin resistance
Persistent elevation of plasma TNF-α is a marker of low grade systemic inflammation. Palmitic acid (PA) is the most abundant type of saturated fatty acid in human body. PA is bound with albumin in plasma and could not pass through endothelial barrier freely. Albumin-bound PA has to be transported across monolayer endothelial cells through intracellular transcytosis, but not intercellular diffusion. In the present study, we discovered that TNF-α might stimulate PA transcytosis across cardiac microvascular endothelial cells, which further impaired the insulin-stimulated glucose uptake by cardiomyocytes and promoted insulin resistance. In this process, TNF-α-stimulated endothelial autophagy and NF-κB signaling crosstalk with each other and orchestrate the whole event, ultimately result in increased expression of fatty acid transporter protein 4 (FATP4) in endothelial cells and mediate the increased PA transcytosis across microvascular endothelial cells. Hopefully the present study discovered a novel missing link between low grade systemic inflammation and insulin resistance.
- 17 March 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 44659
Open AccessTNF-α stimulates endothelial palmitic acid transcytosis and promotes insulin resistance
Persistent elevation of plasma TNF-α is a marker of low grade systemic inflammation. Palmitic acid (PA) is the most abundant type of saturated fatty acid in human body. PA is bound with albumin in plasma and could not pass through endothelial barrier freely. Albumin-bound PA has to be transported across monolayer endothelial cells through intracellular transcytosis, but not intercellular diffusion. In the present study, we discovered that TNF-α might stimulate PA transcytosis across cardiac microvascular endothelial cells, which further impaired the insulin-stimulated glucose uptake by cardiomyocytes and promoted insulin resistance. In this process, TNF-α-stimulated endothelial autophagy and NF-κB signaling crosstalk with each other and orchestrate the whole event, ultimately result in increased expression of fatty acid transporter protein 4 (FATP4) in endothelial cells and mediate the increased PA transcytosis across microvascular endothelial cells. Hopefully the present study discovered a novel missing link between low grade systemic inflammation and insulin resistance.